Insulin glargine: Revision history

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

20 March 2024

  • curprev 11:0011:00, 20 March 2024 Fire talk contribs 9,644 bytes +327 Marked this version for translation
  • curprev 11:0011:00, 20 March 2024 Fire talk contribs 9,317 bytes −4 No edit summary
  • curprev 08:5808:58, 20 March 2024 Fire talk contribs 9,321 bytes +9,321 Created page with "{{Short description|Long-acting insulin}} {{Infobox drug | Verifiedfields = changed | verifiedrevid = 458271727 | image = Toujeo 300 IU-ml inj.jpg | width = | alt = | caption = Toujeo branded insulin glargine <!-- Clinical data --> | pronounce = | tradename = Lantus, Toujeo, Basaglar, others | Drugs.com = {{drugs.com|monograph|insulin_glargine}} | MedlinePlus = a600027 | DailyMedID = Insulin_glargine | pregn..."